Characterization of novel inhibitors of cyclin-dependent kinases

Biochemical and Biophysical Research Communications

Volumn 260, Issue 3, 1999, Pages 768-774

  Kent, Lorraine L ^a   Hull Campbell, Nicolina E ^a   Lau, Ted ^a   Wu, John C ^a   Thompson, Stewart A ^a   Nori, Mukund ^a  

^a BAYER AG   (Germany)

Author keywords

Anticancer agents; Cdk4; Inhibitors; Novel; pRb

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; TUMOR;

EID: 0033554061     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1999.0891     Document Type: Article

References (32)

1. Morgan D. O. Curr. Opin. Genet. Dev. 2:1992;33-37.
2. Pardee A. B. Science. 246:1989;603-608.
3. Pines J. Biochem. Soc. Trans. 21:1993;921-925.
4. van-den-Heuvel S., Harlow E. Science. 262:1993;2050-2054.
5. Bates S., Bonetta L., MacAllan D., Parry D., Holder A., Dickson C., Peters G. Oncogene. 9:1994;71-79.
6. Matsushime H., Ewen M. E., Strom D. K., Kato J.-Y., Hanks S. K., Roussel M. F., Sherr C. J. Cell. 71:1992;323-334.
7. Bartkova J., Lukas J., Muller H., Strauss M., Gusterson B., Bartek J. Cancer. Res. 55:1995;949-956.
8. Gillet C., Fantl V., Smith R., Fisher C., Bartek J., Dickson C., Barnes D., Peters G. Cancer. Res. 54:1994;1812-1817.
9. Peters G. J. Cell. Sci. Suppl. 18:1994;89-96.
10. Zhang Y. J., Jiang W., Chen C. J., Lee C. S., Kahn S. M., Santella R. M., Weinstein I. B. Biochem. Biophys. Res. Commun. 196:1993;1010-1016.
11. Hartwell L. H., Kastan M. B. Science. 266:1994;1821-1828.
12. Hunter T., Pines V. Cell. 66:1991;1071-1074.
13. Sansano H., Frost A. R., Saitoh R., Taniyama Y., Nagura H., Matsunaga G., Takehana K., Kimura M., Silverberg S. G. Anticancer Res. 17:1997;3685-3690.
14. Kamb A., Gruis N. A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S. V., Stockert E., Day 3rd R. S., Johnson B. E., Skolnick M. H. Science. 264:1994;436-440.
15. Nobori T., Miura K., Wu D. J., Lois A., Takabayashi K., Carson D. A. Nature. 368:1994;753-736.
16. Liggett W. H. Jr., Sidransky D. J. Clin. Oncol. 16:1998;1197-1206.
17. Arber N., Doki Y., Han E. K., Sgambato A., Zhou P., Kim N. H., Delohery T., Klein M. G., Holt P. R., Weinstein I. B. Cancer Res. 57:1997;1569-1574.
18. Driscoll B., Wu L., Buckley S., Hall F. L., Anderson K. D., Warburton D. Am. J. Physiol. 273:1997;L941-L949.
19. Schrump D. S., Chen A., Consoli U. Cancer Gene Ther. 3:1996;131-135.
20. Zhou P., Jiang W., Zhang Y.-J., Kahn S. M., Schieren I., Santella R. M., Weinstein I. B. Oncogene. 11:1995;571-580.
21. Lukas J., Bartek J., Strauss M. J. Immunol. Methods. 170:1994;255-259.
22. Tam S. W., Theodoras A. M., Shay J. W., Draetta G. F., Pagano M. Oncogene. 9:1994;2663-2674.
23. Bates S., Parry D., Bonetta L., Vousden K., Dickson C., Peters G. Oncogene. 9:1994;1633-1640.
24. Kitagawa M., Okabe T., Ogino H., Matsumoto H., Suzuki-Takahashi I., Kokubo T., Higashi H., Saitoh S., Taya Y., Yasuda H. Oncogene. 8:1993;2425-2432.
25. Someya A., Tanaka N., Okuyama A. Biochem. Biophys. Res. Commun. 198:1994;536-545.
26. Worland P. J., Kaur G., Stetler-Stevenson M., Sebers S., Sartor O., Sausville E. A. Biochem. Pharmacol. 46:1993;1831-1840.
27. Carlson B. A., Dubay M. M., Sausville E. A., Briyuela L., Worland P. J. Cancer Res. 56:1996;2973-2978.
28. Schulze-Gahmen U., Brandsen J., Jones H. D., Morgan D. O., Meijer L., Vesely J., Kim S.-H. Proteins. 22:1995;378-391.
29. Buquet-Fagot C., Lallemand F., Montagne M. N., Mester J. Anticancer Drugs. 8:1997;623-631.
30. Schutte B., Nieland L., van Engeland M., Henfling M. E., Meijer L., Ramaekers F. C. Exp. Cell Res. 236:1997;4-15.
31. Cleland W. W. Biochim. Biophys. Acta. 67:1963;173-187.
32. Cleland W. W. Adv. Enzymol Relat. Areas Mol. Biol. 29:1967;1-32.